Strategy

A small molecule approach to regenerative medicine

Read more

Calliditas makes debut on Nasdaq Stockholm

Read more

Building a culture of entrepreneurship in Nigeria

Read more

Organs-on-chips enter the laboratories of big pharma

Read more

The myth of biotech self-determination

Read more

Pharma slow to adopt SE incorporation

Read more

Ownership lessons for European biotechs

Read more

Sourcing antibiotics from the nematode worm

Read more

Innovation spreads across the oncology sector

Read more

European pharma plans new strategies for R&D

Read more